iOnctura
Developing precision small molecules to combat hard-to-treat tumors.
Geneve, Switzerland
28 employees
Series B
Total: $118.37M
Biotechnology, Health Care +2
General Information
Geneve, Switzerland
BounceWatch is an independent company data service, not affiliated with iOnctura. To contact iOnctura, visit ionctura.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does iOnctura compare?
A PDF of iOnctura and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting iOnctura soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Switzerland Market
Biotechnology
About iOnctura
Business keywords: biotech, cancer therapy, drug development, clinical-stage, cancer treatment, PI3Kδ inhibitor, autotaxin inhibitor, tumor survival pathways, immunotherapy, precision medicine, oncology, investors, clinical trial, innovation, targeted therapy
Funding Rounds & Investors (9)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | €80.00M | 7 |
|
20 Jun 2024 |
| Grant | €367.73K | 1 |
KWF Kankerbestrijding
|
15 May 2024 |
| Grant | Undisclosed | 2 |
|
03 May 2023 |
| Venture Round | €15.00M | 1 |
|
20 Dec 2022 |
| Grant | €2.50M | 1 |
|
20 Dec 2022 |
| Debt Financing | Fr.400.00K | 1 |
FONGIT Innovation Fund
|
22 Sep 2022 |
| Series A | €5.10M | 5 |
|
14 Jul 2020 |
| Series A | €15.00M | 4 |
|
23 Jan 2020 |
| Seed Round | Undisclosed | 1 |
|
20 Jun 2017 |
Latest News
View All
iOnctura Alternatives & Competitors
View All Alternatives
Overcoming Resistance In Cancer
A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...
TARGETING DIFFICULT TO TREAT CANCERS
Treadwell Therapeutics, Inc.
FAQ About iOnctura
Source: BounceWatch company record for iOnctura, https://bouncewatch.com/company/ionctura, updated 25 November 2024. When citing, please name BounceWatch and link this page.
